Find and Pitch Jounalists, Get Your Story Covered

Tags: Acino M8 Pharmaceuticals acquisition Camber Pharmaceuticals Generic Alesse

	Profile	Recent Articles on Subject
1	Marilyn Bulloch, PharmD, BCPS Pharmacy Times	Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023 - 5 months ago
2	Anne Thomas Hooper, PharmD candidate 2024 Pharmacy Times	Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023 - 5 months ago
3	Maddie Cheak, PharmD candidate 2024 Pharmacy Times	Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023 - 5 months ago
4	Nicholas Florko STAT News Reports on US health business. Washington, DC healthcarepolicy	STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny - 5 months ago
5	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	What are pharma’s next blockbusters? - 5 months ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - 5 months ago The digital therapeutics revolution is here. Will payers play ball? - 5 months ago As alcohol-related deaths climb, new drugs could curb the urge to drink - 6 months ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - 7 months ago
6	Oracle Life Sciences Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
7	Seema Verma Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
8	SVP and GM Pharma Voice	Trends shaping the pharmaceutical industry in 2024 - 5 months ago
9	W. Perry Flowers, RPh, MS Pharmacy Times	Pharmacy Automation Can Be a Means to Drug Safety - 5 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 5 months ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - 5 months ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - 6 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - 7 months ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - 7 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 8 months ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - 8 months ago

Journalists covering Pharmaceuticals